A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers
NCT07495514 · Status: ENROLLING_BY_INVITATION · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-03-27
Summary
A Study to Evaluate the Effect of Food on the Pharmacokinetic Characteristics and Safety Profile of AD-117 in Healthy Adult Volunteers
Conditions
- Mixed Dyslipidemia
- Food Effect Study of AD-117
Interventions
- DRUG
-
AD-117
AD-117 1Tab., Per Oral
Sponsors & Collaborators
-
Addpharma Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-28
- Primary Completion
- 2026-03-31
- Completion
- 2026-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Pharmacokinetics and Safety Profile of CKD-333
NCT03659149 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Pharmacokinetics of AD-104-A
NCT05703282 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers
NCT04019743 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
NCT06088017 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391
NCT05634447 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT06399055 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519
NCT02894541 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
NCT07312799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants
NCT05581758 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03210649 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150
NCT01118559 ·Status: COMPLETED ·Phase: PHASE1
-
A Food Effects Study and Optional Multi Dose Study to Assess PK of BTD-001
NCT03150498 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers
NCT04150146 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Pharmacokinetics and Safety of CKD-391
NCT04354987 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
NCT04611932 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
NCT05552495 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study to Investigate the Effect of Food on the Pharmacokinetics of YM150 Tablet
NCT01125670 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949
NCT02099071 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects
NCT07027982 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-227 in Healthy Adults
NCT05818956 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants
NCT06397508 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT05335044 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers
NCT02533102 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunteers
NCT03920579 ·Status: UNKNOWN ·Phase: PHASE1
-
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
NCT05192356 ·Status: COMPLETED ·Phase: PHASE1